Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
0.2100
-0.0700 (-25.00%)
At close: Jun 29, 2026, 4:00 PM EDT
0.2089
-0.0011 (-0.52%)
After-hours: Jun 29, 2026, 7:59 PM EDT

Jupiter Neurosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
935354---
Market Cap Growth
-75.40%-90.08%----
Enterprise Value
11.5240.45354.43000
Last Close Price
0.211.0210.70---
PS Ratio
223.841612.01----
PB Ratio
--19.1884.90---
P/TBV Ratio
--73.82---
EV/Sales Ratio
284.911856.06----
Debt / Equity Ratio
-1.73-2.890.04-0.38-0.26-0.18
Net Debt / Equity Ratio
-1.74-2.900.05-0.38-0.26-0.13
Net Debt / EBITDA Ratio
-1.06-0.60-0.07-0.57-0.53-0.17
Net Debt / FCF Ratio
-1.41-0.98-0.06-4.62-1.47-0.38
Asset Turnover
-0.00000.520
Inventory Turnover
-0.05----
Quick Ratio
-0.0000.000.010.06
Current Ratio
0.020.040.060.000.010.08
Return on Equity (ROE)
190.94%-738.83%299.46%73.91%80.47%107.64%
Return on Assets (ROA)
-95.91%-151.43%-97.35%-2013.22%-759.96%-635.93%
Return on Invested Capital (ROIC)
-43.14%-105.43%-61.95%-121.89%-185.24%-667.96%
Return on Capital Employed (ROCE)
197.69%-754.53%432.33%61.21%57.03%88.74%
Buyback Yield / Dilution
-15.57%-20.31%-9.01%-0.13%-7.56%-4.25%
Total Shareholder Return
-15.57%-20.31%-9.01%-0.13%-7.56%-4.25%
SEC Filings: 10-K · 10-Q